E Pharma Middle East SAL

What E Pharma Middle East SAL does

E Pharma Middle East SAL is a Lebanon-based pharmaceutical distribution company founded in 2018 that exclusively markets dermo-aesthetic and medical device products to verified healthcare professionals and pharmacies. The company operates as the authorized exclusive distributor in Lebanon for IBSA Italia (Profhilo bioremodeling injectables, Aliaxin hyaluronic acid fillers, Viscoderm skin boosters), md:ceuticals (mesotherapy solutions, chemical peels, depigmentation treatments, home care), JBP Korea (premium injection needles and cannulas including the Nanoneedle 34G 4mm and Nano Cannula series), and Better Booty Lift (BBL recovery pillow). Distribution is gated behind a professional account verification system requiring syndicate membership and clinic credentials, restricting sales to dermatologists, plastic surgeons, aesthetic physicians, and qualified injectors across a network of 496 HCPs.

The underlying product technologies are upstream principals' patented processes rather than E Pharma's own IP — notably IBSA's NAHYCO Hybrid Technology (BDDE-free stabilized hybrid HA complexes used in Profhilo) and SHYALT Ultrapure Technique, and md:ceuticals' Cell Switch Technology combining exosomes with polynucleotides and hyaluronic acid. E Pharma layers on practitioner education through the Master Injector Academy sub-brand (video tutorials and exclusive content) and event-driven engagement including the Annual Congress of Lebanese Society of Dermatology, IBSA Derma MENA Masterclasses, and Aesthetic Day Lebanon. Recent portfolio expansion has added exosome-based regenerative products (Aug 2024) and an expanded Nano Cannula range (Feb 2024).

The business model is B2B pharmaceutical distribution with transaction-fee economics on product sales to HCPs and pharmacies; pricing is not publicly disclosed and is obtained via account-based inquiry. Revenue is generated across injectable aesthetics (highest-margin SKUs), topical skincare, mesotherapy cocktails, chemical peels, and medical devices. The firm reports 8 employees, claims MENA geographic reach, and operates without disclosed external funding, making it a founder-managed private distribution business.

Name

E Pharma Middle East SAL

Legal name

E Pharma Middle East SAL

Website

https://epharma-me.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

E Pharma Middle East SAL is a Lebanon-founded (2018) exclusive pharmaceutical distributor selling dermo-aesthetic injectables, mesotherapy products, peels, and medical devices from IBSA, md:ceuticals, and JBP Korea to verified healthcare professionals and pharmacies in Lebanon and the broader MENA region.

Ownership category

akta.pro rank

Product category

Dermo-Aesthetic Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industry

Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)

Keywords

• Pharmaceutical distribution
• Dermo-aesthetic products
• Hyaluronic acid fillers
• Mesotherapy solutions
• Professional skincare distribution

Headquarters

HQ city

Ain Saadeh

HQ country

Lebanon

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Distribution: B2B distribution of dermo-aesthetic pharmaceutical products including hyaluronic acid fillers, bioremodeling solutions, mesotherapy products, and professional skincare to healthcare professionals and pharmacies in Lebanon and the Middle East region.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

E Pharma Middle East SAL is a B2B pharmaceutical distribution company that sells dermo-aesthetic products exclusively to verified healthcare professionals and pharmacies in Lebanon and the broader Middle East. The company acts as the authorized exclusive distributor for IBSA Italia's dermo-aesthetic product line (Profhilo bioremodeling, Aliaxin hyaluronic acid fillers, Viscoderm skin boosters), md:ceuticals professional skincare and mesotherapy products, JBP Korea premium injection needles and cannulas, and Better Booty Lift recovery products.

Product overview

E Pharma Middle East is a pharmaceutical distribution company that distributes four main product lines to healthcare professionals in Lebanon: IBSA Derma products (Profhilo bioremodeling injectables and Aliaxin hyaluronic acid fillers, Viscoderm skin boosters), md:ceuticals professional dermo-cosmetics (mesotherapy solutions, chemical peels, depigmentation treatments, home care products), JBP Korea medical devices (premium needles and cannulas for cosmetic injections), and Better Booty Lift recovery products. The company operates as an exclusive distributor for IBSA Italia and md:ceuticals in Lebanon, selling exclusively to medical professionals. The portfolio spans injectable aesthetic treatments (fillers, bioremodeling, skin boosters), topical skincare (creams, peels, ampoules), and medical devices (needles, cannulas), serving dermatologists and aesthetic practitioners.

Differentiator

Problem solved

Functional benefit

Brands

• Master Injector Academy: A training platform providing video tutorials and exclusive content for qualified injectors and healthcare professionals in the aesthetics field.

Products and services

• IBSA Derma Product Line Complete range of IBSA pharmaceutical derma-aesthetic products including Profhilo bioremodeling injectables and Aliaxin hyaluronic acid fillers distributed exclusively in Lebanon for dermatologists, plastic surgeons, and aesthetic physicians.
• md:ceuticals Product Line Professional dermo-cosmetic product line including mesotherapy solutions, chemical peels, depigmentation treatments, and home care products for hyperpigmentation, skin aging, wrinkles, photo-damage, and acne, distributed exclusively in Lebanon to medical professionals.
• JBP Korea Medical Devices Premium Japanese-quality injection needles and cannulas including Nanoneedle and Nano Cannula series for cosmetic treatments, with FDA, CE, and MFDS approvals, distributed in Lebanon to medical professionals.
• JBP Nano Cannula Series New generation cannulas in multiple sizes (22G 50mm, 22G 70mm, 25G 50mm, 25G 70mm, 27G 50mm) designed to reduce subcutaneous tissue damage with smooth injection and minimal pain, for use by medical professionals in cosmetic treatments.
• Profhilo 64mg/2ml Pioneer bioremodeling injectable with high HA concentration (64mg/2ml) using NAHYCO hybrid technology for improving skin laxity of face, neck, and décolletage, for use by medical professionals.
• md:complex GenX Exosomes and Polynucleotides Regen Cell Switch technology product combining exosomes, polynucleotides, and hyaluronic acid for signaling skin regeneration and rejuvenation processes, designed for professional aesthetic use by medical professionals.
• Better Booty Lift BBL Pillow High-quality ergonomic pillow made with medical-grade memory foam, medically recommended for Brazilian Butt Lift procedure recovery, exclusively supplied in the Lebanese market.

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• IBSAcoreChannel Partner/ Reseller/ DistributorIBSA is a Swiss multinational pharmaceutical company founded in 1945 in Lugano with products distributed in over 80 countries. IBSA Derma is a pioneer in pharmaceutical research and innovative technologies for ultrapure hyaluronic acid production, controlling the entire pipeline from raw material to pre-filled syringes. E Pharma Middle East S.A.L. is the authorized exclusive distributor for IBSA Italia's dermoesthetic product line in Lebanon.
• md:ceuticalscoreChannel Partner/ Reseller/ Distributormd:ceuticals is an international company based in the United Kingdom with products distributed in more than 40 countries. The company specializes in professional and daily care aesthetic products for hyperpigmentation, skin aging, wrinkles, and photo-damage treatment. Products are approved by dermatologists with efficacy proven in clinical trials. E Pharma Middle East S.A.L is the authorized exclusive distributor for md:ceuticals products in Lebanon.
• JBP (Japan Bio Products)coreChannel Partner/ Reseller/ DistributorJapan Bio Products Co. Ltd is a global pharmaceutical company established in 1954 in Tokyo, Japan. Specialized in developing medical devices including Super Ultra-thin-walled needle/cannula products using Japanese state-of-the-art precision metal cutting/polishing technology. JBP holds FDA, CE, and MFDS approvals for their products.
• Better Booty LiftminorChannel Partner/ Reseller/ DistributorBetter Booty Lift is a high-quality ergonomic pillow medically recommended for Brazilian butt lift procedure recovery. The BBL Pillow is exclusively supplied by E Pharma Middle East S.A.L in the Lebanese market.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Galderma: Global dermatology-focused pharmaceutical company offering Restylane fillers, Sculptra, and broader prescription dermatology. Comparable as a much larger incumbent in the same dermo-aesthetic injectable category with established distribution in MENA and beyond.
• Allergan Aesthetics (AbbVie): Aesthetics division of AbbVie with Botox, Juvéderm fillers, CoolSculpting, and SkinMedica. Comparable as the largest aesthetics incumbent whose Juvéderm line competes directly with Aliaxin/Profhilo in Lebanese and MENA clinics.
• Merz Aesthetics: Global aesthetics business behind Belotero fillers, Radiesse, and Ultherapy. Comparable as an incumbent aesthetic brand portfolio overlapping with E Pharma's HA filler and bioremodeling categories, with established physician-channel distribution in MENA.

Direct peers

• Hugel: South Korean aesthetics company offering botulinum toxin (Botulax), HA fillers (The Chaeum), and PDO threads. Comparable as an emerging aesthetics player whose multi-category portfolio and regional distribution model parallel E Pharma's supplier-side strategy.
• Prollenium Medical Technologies: Canadian manufacturer of Revanesse HA fillers distributed through physician channels internationally. Comparable as a mid-sized HA filler specialist competing for the same dermatologist/aesthetic physician customers as E Pharma's IBSA lines.
• Sinclair Pharma: Specialty aesthetics company distributing HA fillers (MaiLi), bio-stimulators (Ellansé), and skincare via physician channels. Comparable to E Pharma as a similar aesthetic-focused specialty distributor with regional partnerships and a focus on dermatology/aesthetics professionals.
• Laboratoires VIVACY: French manufacturer of premium HA fillers (Stylage) and skin boosters distributed via aesthetic physician networks across Europe and MENA. Comparable as a specialty aesthetics player whose products overlap directly with Profhilo/Aliaxin at dermatology clinics.
• Teoxane: Swiss manufacturer of hyaluronic acid dermal fillers (RHA line) and skincare, sold globally through aesthetic physician channels. Comparable as a premium HA-focused aesthetics player whose products compete in the same physician-dispensed category as IBSA Aliaxin and Profhilo.
• Croma-Pharma: Austrian manufacturer and distributor of hyaluronic acid-based aesthetic products (fillers, skin boosters, threads). Comparable to E Pharma because both specialize in HA-based dermo-aesthetic injectables and operate multi-country distribution networks targeting dermatologists and aesthetic physicians.

Emerging players

• md:ceuticals: UK-based professional dermo-cosmetic brand whose products E Pharma distributes. Comparable as a brand owner in mesotherapy, peels, and depigmentation with similar physician-channel distribution across 40+ countries, providing a template for E Pharma's own international expansion.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/epharma-me

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about E Pharma Middle East SAL